Articles
Instacart Faces Market Pressure as Amazon Expands Grocery Delivery
Shares Drop Amidst Intensifying Competition Despite New Retail Partnerships
Shares of Maplebear Inc., known as Instacart, experienced a notable decline following Amazon's announcement of its expanded grocery delivery service r...
BiomX Sees Significant Investor Entry Driving Stock Surge
Pyu Pyu Capital's Nearly 20% Stake Sparks Renewed Market Interest in PHGE
Shares of BiomX Inc (PHGE) experienced a substantial increase following a 13D regulatory filing revealing Pyu Pyu Capital's acquisition of a nearly 20...
Groceries on Credit: Why Affirm Is Worth a Swing Trade as BNPL Moves into Essentials
Affirm's shift from discretionary e-commerce to everyday spend, improving profitability, and a large loan book justify a tactical long — but watch credit and funding risks.
Affirm (AFRM) is showing the financial profile of a maturing BNPL lender: large transaction volume ($36B in fiscal 2025), the majority of volume comin...
Aclaris Therapeutics Advances Alopecia Treatment with ATI-2138 Showing Superior Preclinical Outcomes
ATI-2138 Demonstrates Accelerated and Sustained Hair Regrowth Compared to Pfizer’s Ritlecitinib in Severe Alopecia Model
Aclaris Therapeutics has revealed compelling preclinical findings for its investigational drug ATI-2138, used to treat alopecia areata (AA). In mouse ...
Affirm Holdings Partners with Bolt to Expand Buy-Now-Pay-Later Options Amid Mixed Stock Movement
Strategic integration aims to enhance payment flexibility at checkout while shares trade in a narrow band
Affirm Holdings, Inc. announced a significant collaboration with Bolt, the commerce platform specializing in fast checkout solutions, designating Affi...
Intellia Therapeutics Sees Share Price Surge After FDA Lifts Clinical Hold on Key Trial
Regulatory Developments Affect Phase 3 Study of Nexiguran Ziclumeran in Treating ATTRv-PN Enhance Market Optimism
Intellia Therapeutics experienced a significant increase in its stock price following the U.S. Food and Drug Administration's decision to lift the cli...
Texas Instruments Forecasts Solid Q4 Revenue: Analyst Revisions Signal Mixed Sentiment Ahead of Earnings
Leading analysts adjust price targets and ratings for Texas Instruments as the company approaches its fourth-quarter earnings announcement
Texas Instruments Incorporated is set to announce its Q4 earnings, with expectations of a slight increase in earnings per share and a notable revenue ...
Mesoblast Reports High Survival Rates in Pediatric Patients Using FDA-Approved Ryoncil for Severe Transplant Complication
Early Intervention with Remestemcel-L Yields Promising Outcomes in Treating Steroid-Refractory aGvHD in Children
Mesoblast Limited has shared encouraging data regarding the real-world use of its FDA-approved cell therapy Ryoncil (remestemcel-L-rknd) for children ...
Energy Prices Climb as Boeing Reports Mixed Q4 Performance and Market Reacts
U.S. stock indexes show contrasting movements amid notable earnings reports and commodity shifts
The U.S. stock market presented a mixed picture midweek, with tech stocks driving gains while the Dow Jones Industrial Average declined. Boeing’s sh...
Understanding Frost Quakes: The Causes Behind Sudden Cold-Weather Booms
Rapid Freezing of Soil Moisture Triggers Rare Cryoseism Phenomena Amid Winter's Grip
Frost quakes, also known as cryoseisms, produce sudden booming noises and slight ground vibrations in areas experiencing intense cold. These events oc...
Kazia Therapeutics Updates Clinical Progress for Paxalisib in Advanced Triple-Negative Breast Cancer
Promising early results in metastatic TNBC patients as enrollment and site expansion continue
Kazia Therapeutics Ltd. provided a clinical update on its ongoing Phase 1b trial investigating paxalisib in combination with pembrolizumab and chemoth...
Genenta Science Shifts Focus from Biotech to Defense Sector with Strategic Acquisition Plan
Company Sets Sights on Becoming Leading Industrial Consolidator in National Security Markets
Genenta Science S.p.A. is undertaking a significant strategic transformation, moving away from its prior focus on cell therapy development toward beco...